197A — TAUNS Laboratories Income Statement
0.000.00%
Last trade - 00:00- ¥58bn
- ¥64bn
- ¥19bn
- 69
- 48
- 66
- 68
Annual income statement for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 17,457 | 15,673 | 18,435 | 18,628 |
| Cost of Revenue | ||||
| Gross Profit | 14,682 | 9,200 | 12,498 | 12,775 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 9,502 | 11,005 | 10,411 | 10,384 |
| Operating Profit | 7,955 | 4,668 | 8,024 | 8,244 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 7,976 | 4,655 | 7,835 | 8,202 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 4,481 | 3,035 | 5,774 | 6,315 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 4,481 | 3,035 | 5,774 | 6,315 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | 4,481 | 3,035 | 5,774 | 6,315 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 63 | 32.3 | 54 | 59 |
| Dividends per Share | ||||
| Special Dividends per Share |